Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma

Stopped Study closed Nov 2000 by Amgen, who stopped drug delivery

Conditions

• Malignant Lymphoma

Interventions

• DRUG: r-metHuSCF and Filgrastim
• DRUG: r-metHuSCF and Filgrastim
• DRUG: Chemotherapy plus Filgrastim

Sponsor

Aalborg University Hospital

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]